Chek it out – Orris AI

$attachment$

Chek it out

This is a USG (Ultrasound) Reporting Form from the Department of Health Services, SDH Beerwah (Registration No. 147/PCPNDT/2023), dated 06/04/26.

Here's what I can read from the form:

Patient Details

Name: Gulshans
R/O: (village/address — partially legible)
Sex: F (Female)
Advised by: (doctor's name — partially legible)

Organ-wise Findings

Organ	Finding
Liver	Shows bright echoes (suggesting fatty liver / increased echogenicity)
Gall Bladder	Normal (tick mark)
CBD	Normal
Portal Vein	Normal (tick + "p")
Spleen	Normal
Pancreas	Normal
Right Kidney	Normal ("p" — likely normal size/echotexture)
Left Kidney	Normal
Urinary Bladder	"p b" — likely partially filled / normal
Uterus	Normal
Right Ovary	Normal ("o")
Left Ovary	Normal
Prostate	Normal (tick)

Impressions: Fatty Liver Grade I–II (most likely interpretation of the handwritten text)

Important Notes printed on the form:

"USG is just Impression not diagnosis — Correlate clinically"
"Sex Determination is NOT done here" (PCPNDT Act compliance)

Summary: The ultrasound suggests Grade I–II Fatty Liver (hepatic steatosis), while all other abdominal and pelvic organs appear within normal limits. The patient should follow up with their treating physician for clinical correlation and further management.

⚠️ This is not a medical diagnosis. Please consult the referring doctor for interpretation and advice.

Treatment

Reading File

Finding Sources

Reading File

Based on authoritative gastroenterology textbooks, here is the treatment for Fatty Liver (NAFLD) Grade I–II:

Treatment of Fatty Liver (NAFLD) Grade I–II

1. Lifestyle Modification (First-Line)

Diet:

Target 5–10% body weight loss — improves most features of fatty liver
- 5% weight loss → improves steatosis
- 7–10% weight loss → improves inflammation and liver injury scores
Caloric restriction: reduce by 500–750 kcal per day
Avoid/reduce: saturated fats, high-fructose corn syrup, sugary drinks, refined carbohydrates
Mediterranean diet is preferred — reduces hepatic steatosis
Omega-3 fatty acids (fish oil) — decrease liver fat and triglycerides
Coffee: 2–3 cups/day is associated with decreased risk of fibrosis
Avoid alcohol completely

Exercise:

Aerobic + resistance training 3–4 times per week, targeting ~400 kcal burned per session
Improves insulin resistance; best results when it leads to weight loss

2. Control Associated Metabolic Conditions

Condition	Action
Type 2 Diabetes	Optimize blood sugar control
Dyslipidemia	Statins (e.g., atorvastatin 20 mg) — safe and beneficial
Hypertension	Blood pressure control
Obesity	Weight management program

3. Pharmacotherapy (if lifestyle alone is insufficient)

Drug	Dose	Notes
Vitamin E	800 IU/day	Improves NASH in non-diabetic patients
Pioglitazone	30–45 mg/day	Improves steatosis/inflammation; causes weight gain
Liraglutide / Semaglutide (GLP-1 agonists)	Varies	Effective for histologic resolution; also aids weight loss
Statins	Atorvastatin 20 mg	Improves liver tests; safe in NAFLD
Pentoxifylline	400 mg TID	May improve liver enzymes and histology
Omega-3 supplements	Standard dose	Beneficial for hypertriglyceridemia

For Grade I–II fatty liver without NASH or fibrosis, pharmacotherapy is usually not needed — lifestyle changes are sufficient.

4. Prevention of Progression

Maintain healthy body weight
Exercise regularly
Treat diabetes and dyslipidemia aggressively
Avoid saturated fat, high fructose intake, and alcohol

Prognosis

Grade I–II fatty liver (simple steatosis) is generally benign. With sustained lifestyle changes, one-third of patients achieve remission within 7 years. The main long-term risk is cardiovascular disease, not liver failure — so metabolic risk factor control is critical.

⚠️ This is educational information only. Please follow your doctor's specific advice for treatment and monitoring.

— Sleisenger and Fordtran's Gastrointestinal and Liver Disease, p. 1648 | Goldman-Cecil Medicine, Treatment section

This is a shared conversation. Sign in to Orris to start your own chat.